Trial Profile

An Open-Label Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to or Failing Standard Chemotherapy

Status: Completed

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Jan 2018 Results assessing the safety and tolerability profile of trifluridine/tipiracil (FTD/TPI) in elderly patients with metastatic colorectal cancer, presented at the 2018 Gastrointestinal Cancers Symposium.
06 Jun 2017 Results (n=45) assessing the safety of trifluridine/tipiracil for metastatic colorectal cancer in African American patients, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
02 Jun 2017 Results assessing safety presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com